ATHE Alterity Therapeutics Limited
$2.08▼ -0.48%
Healthcare
Other
Volume 7.9K
Avg Volume (10D) 37.3K
Key Metrics & Fundamentals
Market Cap
$37.87M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.01 - 5.89
% vs 50 MA
-43.61%
% vs 200 MA
-48.07%
RSI-14
18.9
MACD Histogram
-0.0500
Beta (1Y vs SPY)
1.25
Free Cash Flow
-$7.17M
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Ather Energy (NSEI:ATHERENERG) Stock Sees Modest Fair Value Lift On Stronger Growth Assumptions
Simply Wall St. · Oct 9, 2026 1:19 PM ET
Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference
GlobeNewswire · Oct 9, 2026 7:05 AM ET
Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders
GlobeNewswire · Oct 5, 2026 7:05 AM ET
Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target
MT Newswires · Sep 16, 2026 7:11 AM ET
Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
GlobeNewswire · Sep 3, 2026 7:05 AM ET
Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434
GlobeNewswire · Aug 12, 2026 7:05 AM ET
Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference
GlobeNewswire · Aug 6, 2026 7:25 AM ET
Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update
GlobeNewswire · Jul 30, 2026 7:25 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ATHE's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.